1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
TINAVI Medical Technologies Co., Ltd.

TINAVI Medical Technologies Co., Ltd.

688277.SS
TINAVI Medical Technologies Co., Ltd.CN flagShanghai Stock Exchange
18.18
CNY
-0.08
- -
8.48BMarket Cap

Total Valuation

TINAVI Medical Technologies Co., Ltd. carries a market capitalization of 8.48B, placing it among publicly traded companies globally. Its enterprise value stands at 6.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap8.48B
Enterprise Value6.08B

Share Statistics

TINAVI Medical Technologies Co., Ltd. currently has 452.67M shares outstanding.

Shares Outstanding452.67M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 24.89, and the price-to-book ratio stands at -39.02.

PE RatioN/A
PS Ratio24.89
PB Ratio-39.02
P/TBV Ratio4.88
P/FCF Ratio345.80
P/OCF RatioN/A

Enterprise Valuation

EV / Sales24.73
EV / EBITDAN/A
EV / EBITN/A
EV / FCF201.43

Financial Position

TINAVI Medical Technologies Co., Ltd. maintains a current ratio of 3.53, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.70, indicating elevated leverage, while an interest coverage ratio of -10.78 demonstrates limited ability to service its debt obligations.

Current Ratio3.53
Quick Ratio2.08
Debt / Equity16.70
Debt / EBITDA-2.12
Interest Coverage-10.78

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-7.95
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.76

Taxes

Income Tax33.71M
Effective Tax RateN/A

Stock Price Statistics

TINAVI Medical Technologies Co., Ltd.'s stock has gained approximately 25.90028% over the past 52 weeks. The 50-day moving average sits at 18.52, while the 200-day moving average is 19.63.

Beta (5Y)N/A
52-Week Price Change25.90028%
50-Day Moving Average18.52
200-Day Moving Average19.63
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, TINAVI Medical Technologies Co., Ltd. generated 245.84M in revenue and converted that into -132.19M in net income, yielding earnings per share of -0.32. EBITDA reached -102.04M, while operating income came in at -102.04M.

Revenue245.84M
Gross Profit177.69M
Operating Income-102.04M
Pretax Income-105.52M
Net Income-132.19M
EBITDA-102.04M
EBIT-102.04M
Earnings Per Share (EPS)-0.32

Balance Sheet

TINAVI Medical Technologies Co., Ltd. holds 301.81M in cash and equivalents against 216.46M in total debt, resulting in a net debt position of -30.71M. Total book value stands at -156.80M, with working capital of 367.05M providing operational flexibility.

Cash & Cash Equivalents301.81M
Total Debt216.46M
Net Debt-30.71M
Equity (Book Value)-156.80M
Book Value Per Share-0.36
Working Capital367.05M

Cash Flow

After subtracting -17.69M in capital expenditures, free cash flow totaled -17.69M - equivalent to -0.04 per share.

Operating Cash FlowN/A
Capital Expenditures-17.69M
Free Cash Flow-17.69M
FCF Per Share-0.04

Margins

TINAVI Medical Technologies Co., Ltd. operates with a gross margin of 72.28, reflecting its pricing power and cost economics. The operating margin of -41.51 and net profit margin of -53.77 provide insight into operational efficiency.

Gross Margin72.28
Operating Margin-41.51
Pretax Margin-42.92
Profit Margin-53.77
EBITDA Margin-41.51

Dividends & Yields

The company's payout ratio of -5.48 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.02
Dividend YieldN/A
Payout Ratio-5.48
Shareholder Yield-1.62
FCF Yield0.29

Scores

TINAVI Medical Technologies Co., Ltd. posts an Altman Z-Score of 7.27, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score7.27